These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3488189)

  • 1. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
    Calder MA; Croughan MJ; McLeod DT; Ahmad F
    Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
    Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
    Doern GV; Siebers KG; Hallick LM; Morse SA
    Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.
    Ahmad F; McLeod DT; Croughan MJ; Calder MA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):424-5. PubMed ID: 6508272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.
    McLeod DT; Ahmad F; Croughan MJ; Calder MA
    Drugs; 1986; 31 Suppl 3():109-12. PubMed ID: 3732080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Respiratory tract infection with Branhamella catarrhalis].
    Matsumoto K; Nagatake T; Uzuka Y; Rikitomi N; Noguchi Y
    Nihon Naika Gakkai Zasshi; 1982 Dec; 71(12):1696-702. PubMed ID: 6984859
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
    Robinson A; Johnson PC; Griffith SB
    Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
    Ejlertsen T; Skov R
    APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
    Eliasson I; Kamme C
    Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of Branhamella catarrhalis to oral antibiotics.
    Kallings I
    Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands.
    Davies BI; Maesen FP
    Drugs; 1986; 31 Suppl 3():28-33. PubMed ID: 3488195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production.
    Brorson JE; Martinell J; Wilske H
    J Antimicrob Chemother; 1981 Feb; 7(2):208-9. PubMed ID: 6971288
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
    Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.